Taking medications to protect the heart from damage associated with adjuvant breast cancer therapy—medications that are administered in addition to surgery to remove a tumor—did not significantly improve markers of heart ...
May 17, 2021
0
24
When people with human immunodeficiency virus (HIV) develop high blood pressure, the type of medication chosen for their initial treatment may influence their risk of heart disease, stroke and heart failure, according to ...
Apr 5, 2021
0
3
Cardiovascular disease is the leading cause of death in patients with type 2 diabetes, and youth with severe obesity and type 2 diabetes face a high risk of developing cardiovascular disease during their lifetime. However, ...
Dec 10, 2020
0
2
Sacubitril/valsartan reduces NT-proBNP, a biomarker predictive of long-term clinical outcomes in heart failure, but does not improve functional capacity compared to individualized background therapy in patients with heart ...
Aug 31, 2020
0
4
Elderly patients suffering the most common type of heart attack may benefit from more invasive treatment, new research has shown.
Aug 27, 2020
0
7
The Murdoch Children's Research Institute (MCRI) is recruiting patients for a new national trial aiming to identify those at risk of heart damage following cancer treatment.
Aug 7, 2020
0
1
As cancer survivor rates increase with modern treatments, cardiovascular disease (CVD) rates are rising in cancer patients and survivors and CVD has emerged as a leading cause of long-term preventable death in this population. ...
Jun 16, 2020
0
0
More women than men die of heart failure. The reason is that only 50 percent of the heart failure cases among women are caused by having a heart attack, which can be treated with modern methods.
Jan 6, 2020
0
72
A new multinational study shows that the most popular first-line treatment for hypertension is less effective and has more side effects than an alternative that's prescribed much less often.
Oct 24, 2019
2
274
Cardiologist Bertram Pitt, MD, sees promise in combining two new classes of medication into a treatment regimen for patients with cardiovascular disease. Pitt will discuss the advantages of this treatment plan in his clinical ...
Oct 7, 2019
0
1
